Paliperidone Palmitate

Overview

Paliperidone Palmitate is a long-acting injectable atypical antipsychotic used in the treatment of schizophrenia. It is an ester of paliperidone, which is the primary active metabolite of risperidone.

API suppliers (2)

Suppliers of Paliperidone Palmitate backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• Piramal Pharma LimitedIndia1 active DMF
• Dr. Reddy's Laboratories Ltd.India1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (17 approved US products), the latest listed US patent on Paliperidone Palmitate expires 24 Nov 2041. Generic API sourcing typically opens up once these lapse.

Therapeutic areas